AAOS Now, December 2011
-
Preventing muscle loss after surgery
OREF grant recipient seeks to understand role of matrix-degrading enzymes Skeletal muscle atrophy, the consequence of depriving muscles of normal activity, has a profound impact on orthopaedic patients after injury, immobilization, and surgery. Recovery of muscle mass and function greatly extends the rehabilitation period, and some patients never fully recover the full use of their muscles.
-
Who defines quality in orthopaedics?
AAOS sets stage with inaugural Orthopaedic Quality Institute “There is a critical need for data to help us define the strengths and shortcomings of orthopaedic practice in terms of cost and quality,” said AAOS President Daniel J. Berry, MD, during the AAOS inaugural Orthopaedic Quality Institute (OQI), held Oct. 5–6, in Washington, D.C. “AAOS is committed to quality as a core value and will continue to develop tools to assist our members in improving the quality of care for our patients.”
-
Balancing life as a clinician scientist
Life lessons I’ve learned I once asked a wise mentor of mine who was on the verge of retirement how he would change his life if he were to live it again. “I would balance my life and see my children grow” he replied. I never forgot that conversation, which took place around the time that I arrived in Philadelphia to start my new job as a “clinician scientist.” I was facing the same challenges before even starting my career.
-
ORS Forum tackles the challenges of innovation
“Orthopaedics has been widely heralded for its innovation,” said Mohit Bhandari, MD, cochair of the Orthopaedic Research Society (ORS) Clinical Research Forum. “As a field, we have experienced considerable success. But as an orthopaedic community, we will only grow if we learn from our challenges.” The ORS Clinical Research Forum, “The innovation cycle: How can we avoid wrong turns?” will be held Feb. 6, 8:00 a.m.–4:30 p.m., during the 2012 ORS annual meeting in San Francisco.
-
Workshop focuses on novel technologies to identify OA
Cutting-edge diagnostic technologies can lead to early treatment By the time a radiograph reveals the joint space narrowing and other degenerative signs characteristic of osteoarthritis (OA), the disease has often progressed to its end stage where treatment options are limited. “Early diagnosis and treatment of preosteoarthritic conditions will potentially improve the musculoskeletal health of millions of people,” said Constance R.
-
Is it osteoporosis or elder abuse?
The role of the orthopaedist in identifying elder abuse Child abuse and domestic or intimate partner violence are the focus of public awareness campaigns and are treated with passion and seriousness. Unfortunately, elder abuse, which is a prominent concern among the rapidly aging population of the United States, is not handled with the same sense of urgency.
-
OREF expects “bright future” with new CEO
Sharon Mellor, PhD, CAE, has extensive fundraising, executive experience “She has everything the Orthopaedic Research and Education Foundation (OREF) was looking for in a chief executive officer,” said Ramon L. Jimenez, MD, search committee chair and OREF board president-elect, of Sharon K. Mellor, PhD, CAE. The OREF board of trustees recently appointed Dr. Mellor as OREF’s new CEO, and she assumed her new role on Dec. 1, 2011. Sharon K.